← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2007Last known activity
Dec 31, 2018
Defunct as of Jun 1, 2018
Timeline
2000s
- Jun 1, 2003
Angiochem Inc— Founded
2010s
- Jun 1, 2018
Angiochem Inc— Defunct
Drugs by trial phase (7 distinct, 8 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT03613181Lead sponsorPhase 3Dec 31, 2018
- NCT03613181Study directorPhase 3Dec 31, 2018
- NCT02755987Lead sponsorN/AApr 27, 2016
- NCT02048059Study directorPhase 2Apr 1, 2014
- NCT02048059Lead sponsorPhase 2Apr 1, 2014
- NCT01967810Study directorPhase 2Oct 1, 2013
- NCT01967810Lead sponsorPhase 2Oct 1, 2013
- NCT01497665Study directorPhase 2Nov 1, 2011
- NCT01497665Lead sponsorPhase 2Nov 1, 2011
- NCT01480583Lead sponsorPhase 2Oct 1, 2011
- NCT01480583Study directorPhase 2Oct 1, 2011
- NCT00539344Lead sponsorPhase 1Oct 1, 2007
- NCT00539383Lead sponsorPhase 1Oct 1, 2007
Details
- Founded
- Montreal, CA Jun 1, 2003
- Last known activity
- Dec 31, 2018